Using Vanrx Workcells, pharmaceutical companies can bring injectable medicines to market faster. Short changeover times and flexible systems enable agile manufacturing.
Aseptic Filling for Personalized Medicines describes a new solution for the aseptic filling of cell and gene therapies, immuno-oncology, mRNA and other modalities where manufacturing creates a therapy for a single patient.
Download the white paperSeptember 7, 2018 - Blog, cell therapy, Featured, Gene therapy
Manual aseptic processing is definitely not the best approach— it’s the last resort. Vanrx would go a step further and suggest that manual aseptic processing should end. The technologies and process understanding exist to do away with operator-driven aseptic technique.
Read MoreSeptember 5, 2018 - Blog, Featured, Innovation
Press-fit closures for pharmaceutical vials provide a number of benefits for container-closure integrity, manufacturing and marketing differentiation. This blog reviews the benefits of these closures in replacing aluminum crimp caps.
Read MoreSingota Solutions recognized a gap in the market for contract aseptic filling services. They realized that companies developing new drug products and needing to fill batches of 20,000 units or less were underserved by contract manufacturing organizations. They chose Vanrx’s SA25 Aseptic Filling Workcell to provide an agile filling service for vials, syringes and cartridges, with short lead times.
Read the case studyAugust 13, 2018 - Article, Featured, Innovation
Vanrx Pharmasystems’ Microcell Vial Filler was hand-picked by industry magazine Pharmaceutical Manufacturing for a 2018 Pharma Innovation Award. This is the second award presented in 2018 to the Microcell Vial filler, following its Interphex ‘Best in show’ award in April.
Read MoreAugust 1, 2018 - Article, Featured
Data from surveys presented at the March 2018 ISPE Aseptic Conference and PDA Annual Meeting provides important insights into aseptic filling methods, present and future. Pharma companies state that the cost and complexity of replacing the existing systems with conventional RABS and isolator-based filling systems are significant obstacles to doing so. Vanrx suggests that these obstacles can be avoided by adopting fully robotic gloveless isolators, which avoid the cost and complexity of conventional isolator technologies.
Read MoreSep 26 - Sep 26, 2018
Foxborough, MA, USA
E152 (East Hall)
Oct 9 - Oct 11, 2018
Madrid, Spain
4F114
Oct 23 - Oct 24, 2018
Bethesda, MD, USA
Table #7
Get a detailed view of how Aseptic Filling Workcells compare to conventional technologies and help bring drug products to market faster.
Download the white paperOur team members have developed and brought complex drug products to market. We know what you need now, and are designing for the future.
